Therapeutic Proteins Targeting Cancers
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
32
NCT06645808
PET-imaging of Two Vartumabs in Patients With Solid Tumors
Phase: Early Phase 1
Role: Lead Sponsor
Start: Dec 10, 2024
Completion: Jan 31, 2026
Loading map...